mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |